This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $100,000
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
CIHR · 2026 · Principal investigator
- $600,000
Canada Research Chair - Tier 2
CIHR · 2025 · Nominated PI
- $1,510,875
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
CIHR · 2025 · Principal investigator
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
Principal investigators: Selby, Peter L; Agarwal, Sri Mahavir; Melamed, Osnat; Mir, Hassan; Patton, Ian T; Tang, Victor M; Veldhuizen, Scott R; Zawertailo, Laurie A
Keywords: Addiction; Cardiometabolic Risk; Gastric Inhibitory Peptide; Glucagon-Like Peptide-1 Receptor Agonist; Nicotine Dependence; Obesity; Overweight; Smoking Cessation; Tobacco Use Disorder; Trizepatide
Canada Research Chair - Tier 2
Principal investigators: Agarwal, Sri Mahavir
Keywords: Crc
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
Principal investigators: Hahn, Margaret; Agarwal, Sri Mahavir; Kloiber, Stefan M; Mansur, Rodrigo B; Saraf, Gayatri; Taylor, Valerie Hannah
Keywords: Bipolar Disorder; Depression; Insulin Resistance; Metformin; Treatment Resistance
Is increased blood brain barrier permeability a feature of first-episode psychosis? A combined cross-sectional and longitudinal DCE-MRI study
Principal investigators: Smith, Emily C
Keywords: Antipsychotics; Blood-Brain Barrier; Cognition; Dynamic Contrast Enhanced Mri; First-Episode Psychosis; Insulin Resistance; Optical Coherence Tomography; Schizophrenia Spectrum Disorders; Treatment Response
Trajectories of Neurobiology in Schizophrenia spectrum disorders informing Functional Outcomes and Related Metabolic outcomes (TraNSFORM)
Principal investigators: Neufeld, Nicholas; Agarwal, Sri Mahavir
Keywords: Brain Health; Metabolic Health
Semaglutide in comorbid schizophrenia spectrum illness and obesity for metformin non-responders: a single-blind randomized control trial
Principal investigators: Trang, Serena
Keywords: Antipsychotics; Cognition; Diabetes; Glp-1 Receptor Agonists; Metabolic Adverse Effects; Metformin; Obesity; Severe Mental Illness; Visceral Adiposity
Exploring suicidality risk during semaglutide treatment of obesity in individuals with schizophrenia spectrum illness
Principal investigators: Maksyutynska, Kateryna
Keywords: Diabetes; Obesity; Schizophrenia; Semaglutide; Suicidality; Suicide
Is Increased Blood-Brain Barrier Permeability a Feature of First-Episode Psychosis?
Principal investigators: Panganiban, Kristoffer
Keywords: Blood Brain Barrier; Case-Control; First Episode Psychosis; Imaging; Insulin Resistance; Longitudinal Study; Schizophrenia Spectrum Disorders
Influence of polygenic risk scores on longitudinal disease trajectories of individuals with schizophrenia spectrum disorders
Principal investigators: Kennedy, James L; Tiwari, Arun K; Zai, Clement
Keywords: Disease Severity; Functional Outcomes; Pharmacogenetics; Response; Schizophrenia; Schizophrenia Spectrum Disorders; Side Effects
Strengthening the Delivery of Integrated Care in Specialized Mental Health Settings for Adults Experiencing Serious Mental Illness
Principal investigators: Stergiopoulos, Vicky; Kurdyak, Paul A; Canning, Christopher; Lo, Brian F
Keywords: Integrated Care; Physical Health; Policy Recommendations; Psychiatry; Severe Mental Illness
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.